TNKS and hepatocellular carcinoma: Knockdown of TNKS1 and TNKS2 in HCC cell lines by RNA interference resulted in inhibition of cell proliferation and reduction in nuclear β-catenin protein levels, validating the anti-tumor potential of inhibiting these enzymes in the WNT/β-catenin pathway.